REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Budai Korona Patika Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: BUDAI KORONA PATIKA Bt. Profile Updated: October 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Budai Korona Patika Bt. is an enterprise in Hungary, with the main office in Budapest. It operates in the Pharmacies and Drug Stores industry. It was incorporated on June 09, 1999. It currently has a total number of 9 (2024) employees. In 2023, the company reported a net sales revenue increase of 10.13%. Its’ total assets recorded a growth of 14.52%. Budai Korona Patika Bt.’s net profit margin increased by 2.62% in 2023.

Headquarters
Kapas utca 31.
Budapest; Budapest; Postal Code: 1027

Contact Details: Purchase the Budai Korona Patika Bt. report to view the information.

Website: http://www.budaikorona.hu

Basic Information
Total Employees:
Purchase the Budai Korona Patika Bt. report to view the information.
Outstanding Shares:
Purchase the Budai Korona Patika Bt. report to view the information.
Registered Capital:
Purchase the Budai Korona Patika Bt. report to view the information.
Financial Auditors:
Purchase the Budai Korona Patika Bt. report to view the information.
Incorporation Date:
June 09, 1999
Key Executives
Purchase this report to view the information.
Executive Officer
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Budai Korona Patika Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
10.13%▲
Total operating revenue
9.8%▲
Operating profit (EBIT)
383.07%▲
EBITDA
128.86%▲
Net Profit (Loss) for the Period
830.7%▲
Total assets
14.52%▲
Total equity
44.53%▲
Operating Profit Margin (ROS)
2.54%▲
Net Profit Margin
2.62%▲
Return on Equity (ROE)
26.03%▲
Quick Ratio
0.23%▲
Cash Ratio
0.24%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo